TY - JOUR
T1 - Editor's Choice – The Intersocietal IWGDF, ESVS, SVS Guidelines on Peripheral Artery Disease in People With Diabetes Mellitus and a Foot Ulcer
AU - Fitridge, Robert
AU - Chuter, Vivienne
AU - Mills, Joseph
AU - Hinchliffe, Robert
AU - Azuma, Nobuyoshi
AU - Behrendt, Christian Alexander
AU - Boyko, Edward J.
AU - Conte, Michael S.
AU - Humphries, Misty
AU - Kirksey, Lee
AU - McGinigle, Katharine C.
AU - Nikol, Sigrid
AU - Nordanstig, Joakim
AU - Rowe, Vincent
AU - Russell, David
AU - van den Berg, Jos C.
AU - Venermo, Maarit
AU - Schaper, Nicolaas
N1 - Funding Information:
We would like to thank the following external experts for their review of our PICOs for clinical relevance and the guideline document: Sriram Narayanan (Singapore), Rica Tanaka (Japan), Ismail Cassimjee (South Africa), Xu Jun (China), Heidi Corcoran (Hong Kong), Yamile Jubiz (Colombia), Tsvetalina Tankova (Bulgaria), and our patient representatives. Production of the 2023 IWGDF Guidelines was supported by unrestricted grants from: Advanced Oxygen Therapy Inc. Essity, Mölnlycke, Reapplix, and Urgo Medical. These sponsors did not have any communication related to the systematic reviews of the literature or related to the guidelines with working group members during the writing of the guidelines and have not seen any guideline or guideline-related document before publication.
Funding Information:
We would like to thank the following external experts for their review of our PICOs for clinical relevance and the guideline document: Sriram Narayanan (Singapore), Rica Tanaka (Japan), Ismail Cassimjee (South Africa), Xu Jun (China), Heidi Corcoran (Hong Kong), Yamile Jubiz (Colombia), Tsvetalina Tankova (Bulgaria), and our patient representatives. Production of the 2023 IWGDF Guidelines was supported by unrestricted grants from: Advanced Oxygen Therapy Inc., Essity, Mölnlycke, Reapplix, and Urgo Medical. These sponsors did not have any communication related to the systematic reviews of the literature or related to the guidelines with working group members during the writing of the guidelines and have not seen any guideline or guideline-related document before publication.
Publisher Copyright:
© 2023 The Author(s)
PY - 2023/10
Y1 - 2023/10
N2 - Diabetes related foot complications have become a major cause of morbidity and are implicated in most major and minor amputations globally. Approximately 50% of people with diabetes and a foot ulcer have peripheral artery disease (PAD) and the presence of PAD significantly increases the risk of adverse limb and cardiovascular events. The International Working Group on the Diabetic Foot (IWGDF) has published evidence based guidelines on the management and prevention of diabetes related foot complications since 1999. This guideline is an update of the 2019 IWGDF guideline on the diagnosis, prognosis, and management of peripheral artery disease in people with diabetes mellitus and a foot ulcer. For this updated guideline, the IWGDF, the European Society for Vascular Surgery, and the Society for Vascular Surgery decided to collaborate to develop a consistent suite of recommendations relevant to clinicians in all countries. This guideline is based on three new systematic reviews. Using the Grading of Recommendations, Assessment, Development and Evaluation framework clinically relevant questions were formulated, and the literature was systematically reviewed. After assessing the certainty of the evidence, recommendations were formulated which were weighed against the balance of benefits and harms, patient values, feasibility, acceptability, equity, resources required, and when available, costs. Through this process five recommendations were developed for diagnosing PAD in a person with diabetes, with and without a foot ulcer or gangrene. Five recommendations were developed for prognosis relating to estimating likelihood of healing and amputation outcomes in a person with diabetes and a foot ulcer or gangrene. Fifteen recommendations were developed related to PAD treatment encompassing prioritisation of people for revascularisation, the choice of a procedure and post-surgical care. In addition, the Writing Committee has highlighted key research questions where current evidence is lacking. The Writing Committee believes that following these recommendations will help healthcare professionals to provide better care and will reduce the burden of diabetes related foot complications.
AB - Diabetes related foot complications have become a major cause of morbidity and are implicated in most major and minor amputations globally. Approximately 50% of people with diabetes and a foot ulcer have peripheral artery disease (PAD) and the presence of PAD significantly increases the risk of adverse limb and cardiovascular events. The International Working Group on the Diabetic Foot (IWGDF) has published evidence based guidelines on the management and prevention of diabetes related foot complications since 1999. This guideline is an update of the 2019 IWGDF guideline on the diagnosis, prognosis, and management of peripheral artery disease in people with diabetes mellitus and a foot ulcer. For this updated guideline, the IWGDF, the European Society for Vascular Surgery, and the Society for Vascular Surgery decided to collaborate to develop a consistent suite of recommendations relevant to clinicians in all countries. This guideline is based on three new systematic reviews. Using the Grading of Recommendations, Assessment, Development and Evaluation framework clinically relevant questions were formulated, and the literature was systematically reviewed. After assessing the certainty of the evidence, recommendations were formulated which were weighed against the balance of benefits and harms, patient values, feasibility, acceptability, equity, resources required, and when available, costs. Through this process five recommendations were developed for diagnosing PAD in a person with diabetes, with and without a foot ulcer or gangrene. Five recommendations were developed for prognosis relating to estimating likelihood of healing and amputation outcomes in a person with diabetes and a foot ulcer or gangrene. Fifteen recommendations were developed related to PAD treatment encompassing prioritisation of people for revascularisation, the choice of a procedure and post-surgical care. In addition, the Writing Committee has highlighted key research questions where current evidence is lacking. The Writing Committee believes that following these recommendations will help healthcare professionals to provide better care and will reduce the burden of diabetes related foot complications.
KW - Chronic limb threatening ischaemia
KW - Critical limb ischaemia
KW - Diabetes mellitus
KW - Diabetes related foot ulcer
KW - Endovascular intervention
KW - Peripheral artery disease
U2 - 10.1016/j.ejvs.2023.07.020
DO - 10.1016/j.ejvs.2023.07.020
M3 - Article
SN - 1078-5884
VL - 66
SP - 454
EP - 483
JO - European Journal of Vascular and Endovascular Surgery
JF - European Journal of Vascular and Endovascular Surgery
IS - 4
ER -